Importantly, we demonstrated that disruption of METTL14 aggravated metastasis as well as EMT of ccRCC cells and activated the PI3K/AKT signaling pathway via intensification on ITGB4 expression. Here, METTL14 is linked to nonpapillary renal cell carcinoma.